Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-234
Closed -$17.4K 214
2026
Q1
$17.4K Hold
234
0.01% 137
2025
Q4
$17.4K Hold
234
0.01% 137
2025
Q3
$15.8K Sell
234
-15,013
-98% -$997K 0.01% 142
2025
Q2
$15.2M Buy
15,247
+15,013
+6,416% +$900K 0.01% 145
2025
Q1
$14.5K Hold
234
0.01% 144
2024
Q4
$16.9K Hold
234
0.01% 142
2024
Q3
$19.1K Hold
234
0.01% 145
2024
Q2
$17.4K Hold
234
0.01% 149
2024
Q1
$18.2K Hold
234
0.01% 147
2023
Q4
$16.7K Buy
+234
New +$16.3K 0.01% 151

Other funds holding HOLX

Broadwater Capital's HOLX Position: Q2 2026 in Review

Broadwater Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 234 shares — an estimated $17.4K sold.

Broadwater Capital first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $15.2M in Q2 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Broadwater Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Broadwater Capital sold 234 Hologic shares in Q2 2026, an estimated $17.4K.
  • Broadwater Capital first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • Broadwater Capital's Hologic position peaked at $15.2M in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.